Answers are grounded in this paper and cite their sources.
Chronic obstructive pulmonary disease (COPD) is heterogeneous in development, progression, and phenotypes. Little is known about the lung microbiome, sampled by bronchoscopy, in milder COPD and its relationships to clinical features that reflect disease heterogeneity (lung function, symptom burden, and functional impairment). Using bronchoalveolar lavage fluid collected from 181 never-smokers and ever-smokers with or without COPD (GOLD 0-2) enrolled in the SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS), we find that lung bacterial composition associates with several clinical features, in particular bronchodilator responsiveness, peak expiratory flow rate, and forced expiratory flow rate between 25 and 75% of FVC (FEF25–75). Measures of symptom burden (COPD Assessment Test) and functional impairment (six-minute walk distance) also associate with disparate lung microbiota composition. Drivers of these relationships include members of theStreptococcus, Prevotella, Veillonella, Staphylococcus, andPseudomonasgenera. Thus, lung microbiota differences may contribute to airway dysfunction and airway disease in milder COPD.
No takes yet. Share an insight, caveat, or question.
Opron et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: